Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) immobilized on CM5 Chip can bind Human IL-1 alpha Protein, premium grade (Cat. No. ILA-H5214) with an affinity constant of 18.8 μM as determined in a SPR assay (Biacore 8K) (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Rilonacept | RGN-303; KPL-914 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst, 炎朵 | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Arthritis, Juvenile; Inflammation; Scleroderma, Diffuse; Renal Insufficiency, Chronic; Gout; Urticaria; Vascular Diseases; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Pericarditis; Diabetes Mellitus, Type 1; Coronary Artery Disease; Deficiency of interleukin-1 receptor antagonist; Scleroderma, Systemic; Muckle-Wells Syndrome (MWS); Sarcoidosis; Atherosclerosis; Schnitzler Syndrome; Anemia; Still's Disease, Adult-Onset; Familial Mediterranean Fever | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tadekinig alfa (AB2 Bio) | Phase 3 Clinical | Ab2 Bio Ltd | Cytokine Release Syndrome; Macrophage Activation Syndrome; Lymphohistiocytosis, Hemophagocytic | Details | |
Lutikizumab | ABT-981 | Phase 3 Clinical | Abbvie Inc | Colitis, Ulcerative; Osteoarthritis, Knee; Hidradenitis Suppurativa; Osteoarthritis; Crohn Disease; Dermatitis, Atopic | Details |
Bermekimab | T2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1 | Phase 2 Clinical | Xbiotech Inc | Acne Vulgaris; Hematologic Neoplasms; Digestive System Diseases; Diabetes Mellitus, Type 2; Pyoderma Gangrenosum; Scleroderma, Systemic; Neoplasms; Psoriasis; Colorectal Neoplasms; Hidradenitis Suppurativa; Dermatitis, Atopic; Eczema | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
Vilamakitug | XB-2001 | Phase 2 Clinical | Xbiotech Inc | Non-radiographic axial spondyloarthritis; Pancreatic Neoplasms; Arthritis, Rheumatoid; Rheumatic Diseases | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Myocarditis; Plaque psoriasis | Details |
Interleukin-1-alpha targeting antibody (XBiotech) | Phase 1 Clinical | Xbiotech Inc | Details |
This web search service is supported by Google Inc.